These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19238526)

  • 1. Tumor-initiating cells and treatment resistance: how goes the war?
    Lewis MT; Wicha MS
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):1-2. PubMed ID: 19238526
    [No Abstract]   [Full Text] [Related]  

  • 2. Connecting cancer relapse with senescence.
    Pluquet O; Abbadie C; Coqueret O
    Cancer Lett; 2019 Oct; 463():50-58. PubMed ID: 31404612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonheritable cellular variability accelerates the evolutionary processes of cancer.
    Frank SA; Rosner MR
    PLoS Biol; 2012; 10(4):e1001296. PubMed ID: 22509130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
    Biedler JL; Spengler BA; Ross RA
    Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer].
    Gosálvez M; Blanco MF; de Paz E
    Rev Esp Oncol; 1982; 29(4):821-6. PubMed ID: 6927374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current aspects of drug therapy of cancer].
    Vicente J
    Rev Clin Esp; 1970 Dec; 119(6):501-16. PubMed ID: 4928318
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to resistance to anticancer agents.
    Kruh GD
    Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Targeting Drug-resistant and Metastatic Tumors by Interference with Tumor and Microenvironment-related Alterations.
    Perego P
    Curr Med Chem; 2017; 24(26):2808. PubMed ID: 28911301
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacogenomics of drug resistance to protein kinase inhibitors.
    Gillis NK; McLeod HL
    Drug Resist Updat; 2016 Sep; 28():28-42. PubMed ID: 27620953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editoral: ICRF 159.
    Lancet; 1974 Mar; 1(7853):344-5. PubMed ID: 4131178
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical cell biology and cancer.
    Tanneberger S
    Arch Geschwulstforsch; 1972; 39(1):44-7. PubMed ID: 5029394
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor initiating cells.
    Bansal N; Banerjee D
    Curr Pharm Biotechnol; 2009 Feb; 10(2):192-6. PubMed ID: 19199951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer.
    Riganti C; Contino M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells and differentiation therapy.
    Sell S
    Tumour Biol; 2006; 27(2):59-70. PubMed ID: 16557043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dodging a dogma: is treating beyond progression beneficial?
    Naing A; Kurzrock R
    Cancer Chemother Pharmacol; 2013 May; 71(5):1385-6. PubMed ID: 23443308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.